Active immunoprophyilaxis with uromune® decreases the recurrence of urinary tract infections at three and six months after treatment without relevant secondary effects

por Ramírez Sevilla, Cristóbal, Gómez Lanza, Esther, Manzanera, Juan Llopis, Martín, Jose Antonio Romero, Sanz, Miguel Ángel Barranco
Publicado 2019